Sign in
Active, not recruitingNo phase

A 5-year Superion™ IDS Clinical Outcomes Post-Approval Evaluation (SCOPE)

Key facts

Who runs it
Boston Scientific Corporation
Where
Atlanta, Boston, Carlsbad, Charleston, Chicago, Elk Grove Village, Eugene, Fort Lauderdale, Gainesville, Kansas City, Lancaster, Larkspur, Murrells Inlet, New York, Overland Park, Post Falls, Rancho Mirage, Seattle, Spokane, Tyler, Walnut Creek, Waycross, and Ypsilanti, United StatesSee the 23 sites
Trial code
Status
Active, not recruiting
People taking part
166 people enrolled
Started
30 Jan 2020
Expected to end
Feb 2041
Type of study
Interventional
Treatments tested
  • Superion™ IDS device
Record updated
12 November 2026

Who can take part

Age
45 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 10 criteriaShow less

Who can take part

  • 45 years of age or older when written informed consent is obtained
  • Persistent leg/buttock/groin pain, with or without back pain that is consistently relieved by flexion activities (example: sitting or bending over a shopping cart)
  • Diagnosis of degenerative spinal stenosis of the lumbar spine, defined as the narrowing of the midline sagittal spinal canal (central) and/or narrowing between the facet superior articulating process (SAP), the posterior vertebral margin (lateral access), and the nerve root canal (foraminal)
  • Subject signed a valid, IRB-approved informed consent form (ICF) provided in English
  • Subjects, who, in the opinion of the Clinical Investigator, are able to understand this clinical investigation, cooperate with the investigational procedures and are willing to return for all the required post-treatment follow-ups
  • Able to independently read and complete all questionnaires and assessments provided in English

Who cannot take part

  • Participating (or intends to participate) in another drug or device clinical trial that may influence the data that will be collected for this study
  • Has any pain-related diagnosis, medical/psychological condition or external factors that, in the investigator's medical judgment, might confound reporting of study outcomes (e.g. history of pelvic pain, anginal pain, chronic migraine, involved in litigation, workmen's compensation, spinal tumor)
  • Axial back pain only
  • Fixed motor deficit in lower extremity(ies) due to LSS

Where in United States

  • Alliance Spine and Pain CentersAtlanta, United States
  • Brigham and Women's HospitalBoston, United States
  • Coastal Research Institute, LLCCarlsbad, United States
  • The Spine and Nerve Center of Saint Francis HospitalCharleston, United States
  • Rush University Medical CenterChicago, United States
  • Ascension Alexian BrothersElk Grove Village, United States
  • Pacific Sports and Spine, LLCEugene, United States
  • Holy Cross HospitalFort Lauderdale, United States
  • The Orthopaedic InstituteGainesville, United States
  • University of Kansas HospitalKansas City, United States
  • Center for Interventional Pain and SpineLancaster, United States
  • MarinHealth Spine InstituteLarkspur, United States
  • SC Pain and Spine SpecialistsMurrells Inlet, United States
  • Weill Cornell Medical UniversityNew York, United States
  • Neuroscience Research Center, LLCOverland Park, United States
  • North Idaho Day SurgeryPost Falls, United States
  • Vitamed ResearchRancho Mirage, United States
  • Swedish Health ServicesSeattle, United States
  • Northwest Pain CareSpokane, United States
  • Precision Spine CareTyler, United States
  • IPM Medical Group Inc.Walnut Creek, United States
  • Centurion Spine and PainWaycross, United States
  • Michigan Pain SpecialistsYpsilanti, United States

About the trial

What the trial wants to find out

To compile real-world outcomes of the Superion™ IDS in routine clinical practice.

The group in the trial

  • Superion™ IDS deviceTreatment being tested

    Superion™ Indirect Decompression System (IDS)

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Record updated
12 November 2026